KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Opko Health (OPK) Return on Sales (2016 - 2025)

Opko Health's Return on Sales history spans 16 years, with the latest figure at 0.31% for Q4 2025.

  • For Q4 2025, Return on Sales fell 19.0% year-over-year to 0.31%; the TTM value through Dec 2025 reached 0.4%, down 28.0%, while the annual FY2025 figure was 0.4%, 32.0% down from the prior year.
  • Return on Sales reached 0.31% in Q4 2025 per OPK's latest filing, down from 0.14% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 28.79% in Q3 2021 to a low of 7.29% in Q1 2023.
  • Average Return on Sales over 5 years is 0.89%, with a median of 0.25% recorded in 2025.
  • Peak YoY movement for Return on Sales: surged 2874bps in 2021, then tumbled -2927bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.18% in 2021, then tumbled by -152bps to 0.46% in 2022, then increased by 21bps to 0.36% in 2023, then surged by 67bps to 0.12% in 2024, then crashed by -161bps to 0.31% in 2025.
  • Per Business Quant, the three most recent readings for OPK's Return on Sales are 0.31% (Q4 2025), 0.14% (Q3 2025), and 0.95% (Q2 2025).